P2.01-21 Efficacy and Safety of Combing Anlotinib and Erlotinib as a First-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Keyword(s):
Keyword(s):
2019 ◽
Vol 14
(10)
◽
pp. S129
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 14
(10)
◽
pp. S439
◽
Keyword(s):
2019 ◽
Vol 14
(10)
◽
pp. S398
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2008 ◽
Vol 3
(3)
◽
pp. 303-310
◽
Keyword(s):